首页 | 本学科首页   官方微博 | 高级检索  
     


A Randomized Phase II Study of Linsitinib (OSI‐906) Versus Topotecan in Patients With Relapsed Small‐Cell Lung Cancer
Authors:Alberto A. Chiappori  Gregory A. Otterson  Afshin Dowlati  Anne M. Traynor  Leora Horn  Taofeek K. Owonikoko  Helen J. Ross  Christine L. Hann  Taher Abu Hejleh  Jorge Nieva  Xiuhua Zhao  Michael Schell  Daniel M. Sullivan
Affiliation:1. H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA;2. Ohio State University, Columbus, Ohio, USA;3. University Hospitals Case Medical Center, Cleveland, Ohio, USA;4. University of Wisconsin, Madison, Wisconsin, USA;5. Vanderbilt University, Nashville, Tennessee, USA;6. Winship Cancer Institute of Emory University, Atlanta, Georgia, USA;7. Mayo Clinic, Scottsdale, Arizona, USA;8. Johns Hopkins University, Baltimore, Maryland, USA;9. University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA;10. University of Southern California, Los Angeles, California, USA
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号